0001209191-22-058025.txt : 20221121 0001209191-22-058025.hdr.sgml : 20221121 20221121081221 ACCESSION NUMBER: 0001209191-22-058025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221117 FILED AS OF DATE: 20221121 DATE AS OF CHANGE: 20221121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hutson Nancy J CENTRAL INDEX KEY: 0001379222 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37783 FILM NUMBER: 221403535 MAIL ADDRESS: STREET 1: 64 MONTAUK AVENUE CITY: STONINGTON STATE: CT ZIP: 06378 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clearside Biomedical, Inc. CENTRAL INDEX KEY: 0001539029 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452437375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30005 BUSINESS PHONE: 678-270-3631 MAIL ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-11-17 0 0001539029 Clearside Biomedical, Inc. CLSD 0001379222 Hutson Nancy J C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200 ALPHARETTA GA 30005 1 0 0 0 Common Stock 2022-11-17 4 P 0 30000 1.33 A 83000 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.31 to $1.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Mark Ballantyne, Attorney-in-Fact 2022-11-21